Beneficial Effect of Statins in COVID-19–Related Outcomes—Brief Report: A National Population-Based Cohort Study

Although statins are widely prescribed lipid-lowering drugs, there are concerns about the safety of their use in the context of coronavirus disease 2019 (COVID-19), since statins increase the expression of ACE2 (angiotensin-converting enzyme 2). This study aimed to disclose the association between s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2021-03, Vol.41 (3), p.e175-e182
Hauptverfasser:	Lee, Hae-Young, Ahn, Juhee, Park, Juhong, Kyung Kang, Chang, Won, Sung-Ho, Wook Kim, Dong, Park, Jong-Heon, Chung, Ki-Hyun, Joh, Joon-Sung, Bang, Ji Hwan, Hee Kang, Cheong, Bum Pyun, Wook, Oh, Myoung-don
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Child Child, Preschool Clinical and Population Studies Cohort Studies COVID-19 - complications COVID-19 - mortality COVID-19 Drug Treatment Diabetes Complications - drug therapy Diabetes Complications - mortality Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypertension - complications Hypertension - drug therapy Hypertension - mortality Infant Infant, Newborn Male Middle Aged Pandemics Pneumonia - drug therapy Pneumonia - mortality Propensity Score Proportional Hazards Models Pulmonary Disease, Chronic Obstructive - complications Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - mortality Republic of Korea - epidemiology Retrospective Studies SARS-CoV-2 Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!